First Turn Management’s Ascendis Pharma A/S ASND Stock Holding History

First Turn Management's ASND Position: Q2 2026 in Review

First Turn Management increased its Ascendis Pharma A/S (ASND) stake by 37% in Q2 2026, buying an estimated $6.68M and bringing the position to 104,877 shares worth $28M. The position accounts for 2.99% of the portfolio, ranked #14.

First Turn Management first reported a position in ASND in Q4 2023 and has held it in 11 quarters since. The position peaked at $29.1M in Q3 2025. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

• First Turn Management held 104,877 shares of Ascendis Pharma A/S worth $28M as of Q2 2026.
• First Turn Management bought 28,577 Ascendis Pharma A/S shares in Q2 2026, an estimated $6.68M.
• Ascendis Pharma A/S made up 2.99% of First Turn Management's portfolio in Q2 2026, its #14 holding.
• First Turn Management first reported a position in Ascendis Pharma A/S in Q4 2023 and has held it in 11 quarters since.
• First Turn Management's Ascendis Pharma A/S position peaked at $29.1M in Q3 2025.
• 311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on First Turn Management's 13F filing for Q2 2026, filed 14 Aug 2026.